A Follow-Up Study of a European IgG4-Related Disease Cohort Treated with Rituximab.

Backhus, Johanna; Neumann, Christian; Perkhofer, Lukas; Schulte, Lucas A; Mayer, Benjamin; Seufferlein, Thomas; Müller, Martin; Kleger, Alexander

Backhus, Johanna; Neumann, Christian; Perkhofer, Lukas; Schulte, Lucas A; Mayer, Benjamin; Seufferlein, Thomas; Müller, Martin; Kleger, Alexander.

Afiliação

Backhus J; Department of Internal Medicine 1, Ulm University Hospital, 89081 Ulm, Germany.
Neumann C; Department of Internal Medicine 1, Ulm University Hospital, 89081 Ulm, Germany.
Perkhofer L; Department of Internal Medicine 1, Ulm University Hospital, 89081 Ulm, Germany.
Schulte LA; Department of Internal Medicine 1, Ulm University Hospital, 89081 Ulm, Germany.
Mayer B; Institute of Epidemiology and Medical Biometry, Ulm University, 89075 Ulm, Germany.
Seufferlein T; Department of Internal Medicine 1, Ulm University Hospital, 89081 Ulm, Germany.
Müller M; Department of Internal Medicine 1, Ulm University Hospital, 89081 Ulm, Germany.
Kleger A; Department of Internal Medicine 1, Ulm University Hospital, 89081 Ulm, Germany.

J Clin Med ; 10(6)2021 Mar 23.

Article em En | MEDLINE | ID: mdl-33807051

Palavras-chave

IgG4-related disease; Responder Index; autoimmune pancreatitis; rituximab

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: J Clin Med Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Alemanha

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google